Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis

详细信息    查看全文

• 作者：Stanislav N. Tolkachjov ; MD^a ; Roger H. Weenig ; MD^b ; Nneka I. Comfere ; MD^a ; ^c ; ^{comfere.nneka@mayo.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：cutaneous ; peripheral T-cell ; lymphoma ; extranodal ; PTCLU ; PTCL-NOS
• 刊名：Journal of the American Academy of Dermatology
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：75
• 期：5
• 页码：992-999
• 全文大小：1074 K

文摘

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a rare and aggressive disease either originating in or secondarily involving the skin.

Objective

We sought to assess clinical, histopathologic, and prognostic features of patients with cutaneous PTCL-NOS.

Methods

This was a retrospective chart review of patients with cutaneous PTCL-NOS between 1993 and 2013.

Results

Thirty patients with PTCL-NOS were included. Fourteen had skin-only disease and 15 had concurrent skin and systemic disease at presentation. In primary cutaneous PTCL-NOS, the overall survival rate at 5 years was 61% (95% confidence interval, 37-100%; number still at risk, 2). The median overall survival was 5.6 years. Patients were diagnosed a median of 2.4 months from symptom onset. Patients with concurrent disease died a median of 2.1 years after diagnosis. The estimated overall survival rate at 5 years after diagnosis was 29% (95% confidence interval, 13-67%; number at risk, 3). The median overall survival was 3.9 years. Patients were diagnosed a median of 6 months from symptom onset, with a 53% increased risk of death for each year from symptom onset to diagnosis.

Limitations

This was a retrospective study with a limited number of cases.

Conclusions

Age at diagnosis and B-symptoms predict poor survival in patients with cutaneous PTCL-NOS. In addition, poorer survival is observed in patients with multifocal lesions and concomitant skin and systemic PTCL-NOS.